Regenerative Medicine for Parkinson’s Disease

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Regenerative medicine for Parkinson’s disease (PD) is expected to develop dramatically with the advancement of biotechnology as represented by induced pluripotent stem cells. Existing therapeutic strategy for PD consists of medication using L-DOPA, surgery such as deep brain stimulation and rehabilitation. Current treatment cannot stop the progression of the disease, although there is definite therapeutic effect. True neurorestoration is strongly desired by regenerative medicine. This review article describes the historical development of regenerative medicine for PD, with a focus on fetal nigral cell transplantation and glial cell line-derived neurotrophic factor infusion. Subsequently, the current status of regenerative medicine for PD in terms of cell therapy and gene therapy are reviewed. In the end, the future direction to realize regenerative medicine for PD is discussed.

Original languageEnglish
Pages (from-to)113-123
Number of pages11
JournalNeurologia Medico-Chirurgica
Volume55
Issue number2
DOIs
Publication statusPublished - 2015

Fingerprint

Regenerative Medicine
Parkinson Disease
Glial Cell Line-Derived Neurotrophic Factor
Induced Pluripotent Stem Cells
Deep Brain Stimulation
Cell Transplantation
Therapeutic Uses
Substantia Nigra
Biotechnology
Cell- and Tissue-Based Therapy
Genetic Therapy
Disease Progression
Rehabilitation
Therapeutics

Keywords

  • Cell therapy
  • Dopaminergic neuron
  • Gene therapy
  • Induced pluripotent stem cells

ASJC Scopus subject areas

  • Clinical Neurology
  • Surgery

Cite this

Regenerative Medicine for Parkinson’s Disease. / Yasuhara, Takao; Kameda, Masahiro; Agari, Takashi; Date, Isao.

In: Neurologia Medico-Chirurgica, Vol. 55, No. 2, 2015, p. 113-123.

Research output: Contribution to journalArticle

@article{ead4e9bfe4b1454186ecc4a300442733,
title = "Regenerative Medicine for Parkinson’s Disease",
abstract = "Regenerative medicine for Parkinson’s disease (PD) is expected to develop dramatically with the advancement of biotechnology as represented by induced pluripotent stem cells. Existing therapeutic strategy for PD consists of medication using L-DOPA, surgery such as deep brain stimulation and rehabilitation. Current treatment cannot stop the progression of the disease, although there is definite therapeutic effect. True neurorestoration is strongly desired by regenerative medicine. This review article describes the historical development of regenerative medicine for PD, with a focus on fetal nigral cell transplantation and glial cell line-derived neurotrophic factor infusion. Subsequently, the current status of regenerative medicine for PD in terms of cell therapy and gene therapy are reviewed. In the end, the future direction to realize regenerative medicine for PD is discussed.",
keywords = "Cell therapy, Dopaminergic neuron, Gene therapy, Induced pluripotent stem cells",
author = "Takao Yasuhara and Masahiro Kameda and Takashi Agari and Isao Date",
year = "2015",
doi = "10.2176/nmc.ra.2014-0264",
language = "English",
volume = "55",
pages = "113--123",
journal = "Neurologia Medico-Chirurgica",
issn = "0470-8105",
publisher = "Japan Neurosurgical Society",
number = "2",

}

TY - JOUR

T1 - Regenerative Medicine for Parkinson’s Disease

AU - Yasuhara, Takao

AU - Kameda, Masahiro

AU - Agari, Takashi

AU - Date, Isao

PY - 2015

Y1 - 2015

N2 - Regenerative medicine for Parkinson’s disease (PD) is expected to develop dramatically with the advancement of biotechnology as represented by induced pluripotent stem cells. Existing therapeutic strategy for PD consists of medication using L-DOPA, surgery such as deep brain stimulation and rehabilitation. Current treatment cannot stop the progression of the disease, although there is definite therapeutic effect. True neurorestoration is strongly desired by regenerative medicine. This review article describes the historical development of regenerative medicine for PD, with a focus on fetal nigral cell transplantation and glial cell line-derived neurotrophic factor infusion. Subsequently, the current status of regenerative medicine for PD in terms of cell therapy and gene therapy are reviewed. In the end, the future direction to realize regenerative medicine for PD is discussed.

AB - Regenerative medicine for Parkinson’s disease (PD) is expected to develop dramatically with the advancement of biotechnology as represented by induced pluripotent stem cells. Existing therapeutic strategy for PD consists of medication using L-DOPA, surgery such as deep brain stimulation and rehabilitation. Current treatment cannot stop the progression of the disease, although there is definite therapeutic effect. True neurorestoration is strongly desired by regenerative medicine. This review article describes the historical development of regenerative medicine for PD, with a focus on fetal nigral cell transplantation and glial cell line-derived neurotrophic factor infusion. Subsequently, the current status of regenerative medicine for PD in terms of cell therapy and gene therapy are reviewed. In the end, the future direction to realize regenerative medicine for PD is discussed.

KW - Cell therapy

KW - Dopaminergic neuron

KW - Gene therapy

KW - Induced pluripotent stem cells

UR - http://www.scopus.com/inward/record.url?scp=84922936412&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922936412&partnerID=8YFLogxK

U2 - 10.2176/nmc.ra.2014-0264

DO - 10.2176/nmc.ra.2014-0264

M3 - Article

VL - 55

SP - 113

EP - 123

JO - Neurologia Medico-Chirurgica

JF - Neurologia Medico-Chirurgica

SN - 0470-8105

IS - 2

ER -